We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
+1.58%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$805M
AUM Growth
+$2.82M
Cap. Flow
-$5.52M
Cap. Flow %
-0.69%
Top 10 Hldgs %
21.48%
Holding
266
New
7
Increased
69
Reduced
92
Closed
7

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$1.49M
2
JAH
JARDEN CORPORATION
JAH
+$861K
3
AGN
Allergan plc
AGN
+$842K
4
LH icon
Labcorp
LH
+$776K
5
ECL icon
Ecolab
ECL
+$712K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$1.98M
2
AGN
Allergan Inc
AGN
+$1.74M
3
GILD icon
Gilead Sciences
GILD
+$1.33M
4
TFM
THE FRESH MARKET, INC COM STK
TFM
+$1.26M
5
CELG
Celgene Corp
CELG
+$1.22M

Sector Composition

Rank Sector Weight
1 Healthcare 18.07%
2 Industrials 14.98%
3 Miscellaneous 14.57%
4 Technology 12.91%
5 Consumer Staples 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GXC icon
101
State Street SPDR S&P China ETF
GXC
$463M
$2.07M 0.26%
24,425
-5,085
-17% -$412K
K
102
DELISTED
Kellanova
K
$1.99M 0.25%
32,062
– –
DEO icon
103
Diageo
DEO
$48.3B
$1.97M 0.24%
17,793
-371
-2% -$42.7K
WOLF icon
104
Wolfspeed
WOLF
$1.25B
$1.94M 0.24%
54,552
– –
HD icon
105
Home Depot
HD
$304B
$1.87M 0.23%
16,457
-25
-0.2% -$2.76K
THD icon
106
iShares MSCI Thailand ETF
THD
$337M
$1.84M 0.23%
23,150
– –
ESRX
107
DELISTED
Express Scripts Holding Company
ESRX
$1.82M 0.23%
21,024
-799
-4% -$67K
APC
108
DELISTED
Anadarko Petroleum
APC
$1.82M 0.23%
21,949
+100
+0.5% +$8.18K
SSNC icon
109
SS&C Technologies
SSNC
$19.1B
$1.8M 0.22%
57,700
-3,900
-6% -$116K
AGN
110
DELISTED
Allergan plc
AGN
$1.76M 0.22%
5,909
+2,952
+100% +$842K
MDLZ icon
111
Mondelez International
MDLZ
$79.3B
$1.75M 0.22%
48,406
-2,425
-5% -$87.7K
T icon
112
AT&T
T
$184B
$1.69M 0.21%
68,684
+158
+0.2% +$4.02K
WBA
113
DELISTED
Walgreens Boots Alliance
WBA
$1.64M 0.2%
19,375
– –
HUB.B
114
DELISTED
HUBBELL INC CL-B
HUB.B
$1.63M 0.2%
14,870
– –
RDS.A
115
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.59M 0.2%
28,488
– –
MDT icon
116
Medtronic
MDT
$120B
$1.54M 0.19%
+19,713
New +$1.49M
FCX icon
117
Freeport-McMoran
FCX
$99.5B
$1.53M 0.19%
80,854
-4,600
-5% -$91K
NEOG icon
118
Neogen
NEOG
$2.69B
$1.52M 0.19%
86,877
-9,494
-10% -$174K
EEM icon
119
iShares MSCI Emerging Markets ETF
EEM
$30.6B
$1.5M 0.19%
37,417
– –
CLX icon
120
Clorox
CLX
$10.6B
$1.5M 0.19%
13,544
-10
-0.1% -$1.09K
SIAL
121
DELISTED
SIGMA - ALDRICH CORP
SIAL
$1.49M 0.18%
10,768
– –
IQV icon
122
IQVIA
IQV
$44.5B
$1.49M 0.18%
22,183
+775
+4% +$48.9K
TEL icon
123
TE Connectivity
TEL
$58.4B
$1.49M 0.18%
20,730
+635
+3% +$43.6K
V icon
124
Visa
V
$701B
$1.48M 0.18%
22,616
+3,796
+20% +$251K
RTN
125
DELISTED
Raytheon Company
RTN
$1.48M 0.18%
13,536
+825
+6% +$88.7K
3 4
5
6 7

Similar funds

MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.65B AUM 184.75% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Boston Family Office's Q1 2015 Portfolio in Review

As of Q1 2015, Boston Family Office held 266 positions worth $805M, up 0.35% from $803M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q1 2015 filing shows 7 new, 69 increased, 92 reduced and 7 closed positions. Its largest new stake was Medtronic: 19,713 shares worth $1.54M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $1.98M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Miscellaneous.

  • Boston Family Office's largest Q1 2015 buy was Medtronic: 19,713 shares worth $1.54M.
  • Boston Family Office added most to Allergan plc in Q1 2015, an estimated $842K increase.
  • Boston Family Office's biggest Q1 2015 reduction was Gilead Sciences, cutting an estimated $1.33M.
  • Boston Family Office fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $1.98M.
  • Boston Family Office's ten largest holdings make up 21% of its $805M portfolio in Q1 2015.
  • Boston Family Office opened 7 new positions and closed 7 in Q1 2015.
  • Boston Family Office's portfolio value rose 0.35% quarter-over-quarter to $805M.

Based on Boston Family Office's 13F filing for Q1 2015, filed 11 May 2015.